Sangui Biotech International Stock Analysis

Sangui Pink Sheet Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany. Sangui Biotech is traded on OTC Exchange in the United States.The quote for Sangui Biotech International is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sangui Biotech International contact Thomas Striepe at 49 40 609 3120 or learn more at https://www.sanguibiotech.com.

Sangui Biotech Inter Investment Alerts

Sangui Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 902.58 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sangui Biotech's market, we take the total number of its shares issued and multiply it by Sangui Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sangui Profitablity

The company has Profit Margin (PM) of (1.27) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.5) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.5.

Technical Drivers

As of the 25th of March, Sangui Biotech has the Variance of 113.8, risk adjusted performance of (0.10), and Coefficient Of Variation of (812.40). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sangui Biotech Inter, as well as the relationship between them.

Sangui Biotech Inter Price Movement Analysis

Sangui Biotech Outstanding Bonds

Sangui Biotech Predictive Daily Indicators

Sangui Biotech Forecast Models

Sangui Biotech's time-series forecasting models are one of many Sangui Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sangui Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sangui Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sangui shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sangui Biotech. By using and applying Sangui Pink Sheet analysis, traders can create a robust methodology for identifying Sangui entry and exit points for their positions.

When running Sangui Biotech's price analysis, check to measure Sangui Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangui Biotech is operating at the current time. Most of Sangui Biotech's value examination focuses on studying past and present price action to predict the probability of Sangui Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangui Biotech's price. Additionally, you may evaluate how the addition of Sangui Biotech to your portfolios can decrease your overall portfolio volatility.